• Ameneh Jafari, Mostafa Rezaei-Tavirani, Samira Karami, Mohsen Yazdani, Hakimeh Zali, and Zahra Jafari.
• Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
• Risk Manag Healthc Policy. 2020 Jan 1; 13: 1711-1721.

AbstractNew cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.© 2020 Jafari et al.

5 keywords...

hide…